← SynDRA
NETARSUDIL
SynDRA canonical compound SYN0039959 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | ROCK2 |
|---|
| Mechanism of action | rho associated kinase inhibitor |
|---|
| Indication | ocular hypertension |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- ROCK2 INHIBITOR
- Rho-associated protein kinase inhibitor
- ROCK1 INHIBITOR
- rho associated kinase inhibitor
- SLC6A2 MODULATOR
Drug classes
- Rho Kinase Inhibitor
- Rho Kinase Inhibitors
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Cross-references
Synonyms
- rhokiinsa
- netarsudil dimesylate
- netarsudil mesylate
- rhopressa
- AR-13324
- AR-11324 FREE BASE
- UNII-W6I5QDT7QI
- W6I5QDT7QI
- Netarsudil mesylate
- Netarsudil [USAN]
- AR-11324 free base
- Netarsudil [USAN:INN]
- Netarsudil (USAN/INN)
- GTPL9322
- SCHEMBL16036278
- ZINC113149554
- AR11324
- AR-11324
- ester 60
- netarsudilum
- RefChem:57176
- S01EX05
- DTXCID101513350
- Rhokiinsa
- Netarsudil free base
- NETARSUDIL [MI]
- NETARSUDIL [INN]
- NETARSUDIL [WHO-DD]
- orb1738361
- SCHEMBL29351219
- SCHEMBL29673273
- BDBM50546247
- EBC-27135
- EX-A14761
- NCGC00507845-03
- AC-31227
- ester 60 [PMID: 27072905]
- HY-12798
Reported adverse events
- Eye pruritus
- Instillation site erythema
- Foreign body
Look up NETARSUDIL in the interactive SynDRA portal →